| Unique ID issued by UMIN | UMIN000063718 |
|---|---|
| Receipt number | R000072915 |
| Scientific Title | A Retrospective Observational Study of the Association Between Changes in Measured Multi-Hair Follicular Unit Percentage and Treatment Response Across Different Treatment Strategies for Male Androgenetic Alopecia |
| Date of disclosure of the study information | 2026/11/22 |
| Last modified on | 2026/11/21 11:54:23 |
A retrospective observational study of the association between changes in measured MFU% (multi-hair follicular unit rate) and treatment response across different treatment strategies for male androgenetic alopecia
A Retrospective Observational Study of the Relationship Between Changes in Hair Characteristics and Treatment Response in Different Treatments for Male Androgenetic Alopecia
A Retrospective Observational Study of the Association Between Changes in Measured Multi-Hair Follicular Unit Percentage and Treatment Response Across Different Treatment Strategies for Male Androgenetic Alopecia
MFU-Response Study
| Japan |
Male androgenetic alopecia
| Dermatology |
Others
NO
To investigate the association between treatment response (responders vs. non-responders) at 12 months after initial treatment and the change in measured multi-hair follicular unit percentage from baseline to 12 months in patients with male androgenetic alopecia.
Safety,Efficacy
Exploratory
Explanatory
Not applicable
The difference in the change in measured multi-hair follicular unit percentage between the responder and non-responder groups in the pooled pre-analysis population comprising all five treatment groups.
1) The proportions of patients classified as responders and non-responders in each treatment group.
2) Changes in trichoscopic parameters, including maximum hair diameter, terminal hair percentage, and hair density, in each treatment group.
Observational
| 20 | years-old | <= |
| 100 | years-old | >= |
Male
Patients must meet all of the following criteria to be eligible for inclusion in this study:
1. Male patients diagnosed with male androgenetic alopecia.
2. Patients who can be classified into one of the five treatment groups defined in this study: SHED-CM monotherapy, needle radiofrequency (RF) monotherapy, alternating SHED-CM and needle RF therapy, same-day combined SHED-CM and needle RF therapy, or dutasteride monotherapy.
3. Availability of clinical information and trichoscopic images at baseline (T0), before treatment initiation.
4. Availability of trichoscopic images at approximately 12 months after treatment initiation (T12).
5. Availability of evaluable multi-hair follicular unit percentage (MFU%) and QTES measurements from images obtained at both T0 and T12.
Patients meeting any of the following criteria will be excluded from the study:
1. Patients with alopecia other than male androgenetic alopecia (MAGA), or whose hair loss is considered primarily attributable to another disease.
2. Patients with concomitant alopecia areata, scarring alopecia, or other forms of alopecia that may affect trichoscopic assessment.
3. Patients with missing or inadequate-quality trichoscopic images at T0 or T12, preventing reliable assessment of MFU% or QTES.
4. Patients with insufficient medical records to confirm the treatment received, treatment initiation date, or assessment time points.
5. Patients who cannot be classified into any of the five treatment groups defined in this study.
6. Patients who received additional major MAGA treatments during the observation period, making it difficult to assess the association between changes in MFU% and the treatment strategy.
125
| 1st name | Tomoko |
| Middle name | |
| Last name | Kamishima |
Tokyo Midtown Skin/Aesthetic Clinic Noage
Department of Dermatology
107-6206
Midtown Tower 6F 9-7-1 Akasaka Minato-ku Tokyo Japan
0354130082
t-kamishima@tokyomidtown-mc.jp
| 1st name | Asami |
| Middle name | |
| Last name | Ito |
Advanced Medical Care Inc.
Noage Dental Division
107-6206
Midtown Tower 6F 9-7-1 Akasaka Minatoku Tokyo Japan
0354130082
a-ito@amcare.co.jp
Tokyo midtown Center for Advanced Medical Science and Technology
Tokyo midtown Center for Advanced Medical Science and Technology
Profit organization
Tokyo Midtown Medical Center Ethical Review Board
Midtown Tower 6F 9-7-1 Akasaka Minatoku Tokyo Japan
0332312062
k-aramaki@amcare.co.jp
NO
東京ミッドタウン皮膚科形成外科クリニック・ノアージュ
| 2026 | Year | 11 | Month | 22 | Day |
Unpublished
Enrolling by invitation
| 2021 | Year | 01 | Month | 01 | Day |
| 2026 | Year | 11 | Month | 12 | Day |
| 2021 | Year | 01 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
Assessment Time Points
Each patient will be evaluated at two time points: before treatment initiation (T0) and approximately 12 months after treatment initiation (T12).
Definition of T0
Trichoscopic images and clinical information obtained as part of routine clinical practice within 0 to 2 months before the treatment initiation date.
Definition of T12
Trichoscopic images and clinical information obtained as part of routine clinical practice within 10 to 14 months after treatment initiation.
T0 Eligibility Period
January 1, 2021, to March 31, 2027.
Final Deadline for T12 Data Collection
March 31, 2028.
Assessment Methods
Trichoscopic images and clinical information obtained at each time point (T0 and T12) will be used for assessment. Data obtained at 3, 6, and 9 months will not be included in the assessments for this study.
| 2026 | Year | 11 | Month | 21 | Day |
| 2026 | Year | 11 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072915